Clearside Biomedical

Clearside Biomedical, Inc. is a biopharmaceutical company focused on developing innovative treatments for serious eye diseases. Founded in 2011 and headquartered in Alpharetta, Georgia, the company specializes in therapies that restore and preserve vision through its proprietary ocular microinjection platform. This platform allows for non-surgical, targeted delivery of drugs to specific compartments of the eye, including the retina and choroid. Notable products in development include CLS-AX, an axitinib formulation for suprachoroidal injection, and XIPERE, a triamcinolone acetonide injectable suspension intended for the treatment of macular edema associated with uveitis and other conditions. Through its unique suprachoroidal injection approach, Clearside aims to address sight-threatening diseases and improve patient outcomes.